Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan J Feld

Showing results (121-130 of 395) with videos related to

Pageof 40
Sort By:
Hepatology (Baltimore, Md.)|June 15, 2005
Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcomeJordan J Feld, Huong Dinh, Tamara Arenovich, et al.
Plos One|January 24, 2018
Population-based estimate of hepatitis C virus prevalence in Ontario, CanadaShelly Bolotin, Jordan J Feld, Gary Garber, et al.
Plos One|April 16, 2015
Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screeningAlissa Visram, Kelvin K W Chan, Phyllis McGee, et al.
Virus Research|March 20, 2025
Combination therapy enhances the antiviral activity of IFN-λ against SARS-CoV-2 and MERS-CoVVahid Rajabali Zadeh, Jocelyne M Lew, M Atif Zahoor, et al.
Lancet Regional Health. Americas|June 30, 2023
Rapid hepatitis C virus point-of-care RNA testing and treatment at an integrated supervised consumption service in Toronto, Canada: a prospective, observational cohort studyBernadette Lettner, Kate Mason, Zoë R Greenwald, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2016
Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infectionJordan J Feld, Ira M Jacobson, Mark S Sulkowski, et al.
Clinical and Molecular Hepatology|March 18, 2026
SEVERE HEPATITIS B FLARE AND LIVER FAILURE - CURRENT ASSESSMENT AND MANAGEMENTSeng Gee Lim, Maria Buti, Jordan J Feld, et al.
Journal of Hepatology|October 26, 2019
Pitfalls in measuring temporal trends for late diagnosis of viral hepatitisLauren Lapointe-Shaw, Peter C Austin, Hannah Chung, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 30, 2018
Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirinJordan J Feld, David E Bernstein, Ziad Younes, et al.
The Lancet. Infectious Diseases|January 6, 2024
Characterising the effectiveness of social determinants of health-focused hepatitis B interventions: a systematic reviewKikanwa Anyiwe, Aysegul Erman, Marian Hassan, et al.
Pageof 40

Showing results (121-130 of 395) with videos related to

Sort By:
Pageof 40
Hepatology (Baltimore, Md.)|June 15, 2005
Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcomeJordan J Feld, Huong Dinh, Tamara Arenovich, et al.
Plos One|January 24, 2018
Population-based estimate of hepatitis C virus prevalence in Ontario, CanadaShelly Bolotin, Jordan J Feld, Gary Garber, et al.
Plos One|April 16, 2015
Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screeningAlissa Visram, Kelvin K W Chan, Phyllis McGee, et al.
Virus Research|March 20, 2025
Combination therapy enhances the antiviral activity of IFN-λ against SARS-CoV-2 and MERS-CoVVahid Rajabali Zadeh, Jocelyne M Lew, M Atif Zahoor, et al.
Lancet Regional Health. Americas|June 30, 2023
Rapid hepatitis C virus point-of-care RNA testing and treatment at an integrated supervised consumption service in Toronto, Canada: a prospective, observational cohort studyBernadette Lettner, Kate Mason, Zoë R Greenwald, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2016
Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infectionJordan J Feld, Ira M Jacobson, Mark S Sulkowski, et al.
Clinical and Molecular Hepatology|March 18, 2026
SEVERE HEPATITIS B FLARE AND LIVER FAILURE - CURRENT ASSESSMENT AND MANAGEMENTSeng Gee Lim, Maria Buti, Jordan J Feld, et al.
Journal of Hepatology|October 26, 2019
Pitfalls in measuring temporal trends for late diagnosis of viral hepatitisLauren Lapointe-Shaw, Peter C Austin, Hannah Chung, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 30, 2018
Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirinJordan J Feld, David E Bernstein, Ziad Younes, et al.
The Lancet. Infectious Diseases|January 6, 2024
Characterising the effectiveness of social determinants of health-focused hepatitis B interventions: a systematic reviewKikanwa Anyiwe, Aysegul Erman, Marian Hassan, et al.
Pageof 40